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Summary
 
The recent observation that neutralization or genetic deletion of the T lymphocyte receptor
CTLA-4 allows enhanced T cell reactivity offers new opportunities for immunotherapy against
infectious agents. We used a neutralizing antibody to block CTLA-4 interaction with its
ligands CD80 and CD86 during infection of mice with the nematode, 
 
Nippostrongylus brasilien-
sis
 
. CTLA-4 blockade greatly enhanced and accelerated the T cell immune response to 
 
N. bra-
siliensis
 
, resulting in a profound reduction in adult worm numbers and early termination of par-
asite egg production. The ability of CTLA-4 blockade to accelerate primary immune responses
to a protective level during an acute infection indicates its potential as an immunotherapeutic
tool for dealing with infectious agents.
 
T
 
he T cell molecule CTLA-4 is expressed at high levels
on the surface 48–72 h after T cell activation (1) and
functions as a negative regulator of activation (2–5). The ge-
netic deletion of CTLA-4 in mice results in a profound lym-
phoproliferative disease with some of the hallmarks of auto-
immunity (6, 7). Similarly, blockade of CTLA-4 interaction
with its ligands CD80 and CD86 on antigen-presenting cells
with either whole anti–CTLA-4 mAb or monovalent Fab
fragments results in enhanced T cell expansion to either pep-
tide (8) or super antigen (9). However, it is not clear whether
T cell effector function is altered, or whether the observed in-
creases in T cell expansion give rise to an enhanced immune
response. We studied the effects of CTLA-4 blockade on the
immune response to the parasite 
 
Nippostrongylus brasiliensis
 
(Nb)
 
1
 
 as changes in T cell effector function and subsequent ef-
fects on protective immunity could be easily monitored.
Primary infection of mice with Nb is characterized by
migration first to the lung then small intestine (days 2–4)
where final maturation, copulation, and egg production
(days 5–10) occur (10, 11). The adult worms are eventually
expelled from the gut by day 12–14 after infection. Subse-
quent cycles of worm infection come under increasingly
effective immune attack resulting in poor worm maturation
and inhibition of egg production (12). The major immune re-
sponse which is mounted is a CD4
 
1
 
 Th2-type response char-
acterized by IL-4 and IL-5 cytokine production with resulting
eosinophilia, mastocytosis, and IgE production (12–15).
 
Materials and Methods
 
Antibody Treatment.
 
Anti–CTLA-4 mAb (4F10, hamster IgG)
and control hamster IgG were purified from hybridoma superna-
tant and normal hamster serum, respectively, using protein G af-
finity columns. C57BL/6 mice were injected intraperitoneally with
1 mg/wk of either anti–CTLA-4 mAb to block CTLA-4 signal-
ing or hamster IgG as control. Antibody treatment always started
at day 0 of parasite infection. The concentration of circulating
anti–CTLA-4 mAb was directly measured by a sandwich ELISA
using plate-bound mCTLA-4Ig as capture and anti-hamster IgG-
biotin to detect anti–CTLA-4 mAb in the serum. Using this
method anti–CTLA-4 mAb was present in high levels in the se-
rum 7 d after treatment but was not detectable in any of the
treated mice 14 d after the last treatment. In the secondary chal-
lenge experiment, mice were inoculated with infective larvae 47 d
after the final injection of anti–CTLA-4 mAb to ensure no resid-
ual effect of CTLA-4 blockade on the memory response.
 
N. brasiliensis Inoculation and Quantitation of Worms and Eggs.
N. brasiliensis
 
 was maintained by passage through Lewis rats. C57BL/6
mice (6–10 wk old) were inoculated with third-stage infective
larvae by either subcutaneous (750 L3) or intraperitoneal (1,000 L3)
injection. Parasite egg numbers were determined from group samples
of feces collected daily. Adult worm numbers were determined
per mouse by removing small intestine, slicing open longitudi-
nally, cutting into small sections, and suspending in a gauze bag
submerged in PBS at 37
 
8
 
C to allow worms to migrate out and settle
to the bottom. Microscopic analysis of the small intestine revealed
any worms that had remained attached to the intestinal mucosa.
 
Cytokine Production and ELISA.
 
Mediastinal, mesenteric, or
inguinal lymphocytes were cultured at 1 
 
3
 
 10
 
6
 
 cells/200 
 
m
 
l/well
in the presence of 
 
r
 
IL-2 (200 U/ml) in 96-well flat-bottom mi-
croplates coated with anti-CD3 (2C11, 10 
 
m
 
g/ml). After 60 h in-
cubation, supernatants were harvested and kept frozen until analysis.
A sandwich ELISA was used to measure cytokines, using TRFK5
and TRFK4-biotin conjugate (anti–IL-5), and 11B11 and BVD6-
24G2-biotin conjugate (anti–IL-4) as capture and detecting reagents,
respectively. In brief, polyvinyl chloride 96-well plates were coated
overnight at 4
 
8
 
C with 5 
 
m
 
g/ml capture mAb and blocked with
10% BSA in PBS for 60 min at room temperature. Appropriate
dilutions of test supernatants, or mIL-4 or mIL-5 internal stan-
 
1
 
Abbreviation used in this paper:
 
 Nb, 
 
Nippostrongylus brasiliensis.
  
184
 
CTLA-4 Blockade in Nematode Infection
dards, were added and incubated for 2 h at room temperature. Ap-
propriate dilutions of detecting Ab and then peroxidase-labeled
streptavidin were added for 1 h at room temperature. Freshly made
1 mM ABTS (100 
 
m
 
l) in citrate phosphate buffer, pH 9.2, and 0.03%
H
 
2
 
O
 
2
 
 was added to each well to develop the reaction. The reaction
was stopped by adding 100 
 
m
 
l 2 mM NaN
 
3
 
 and the plates read at
414 nM using an Anthos Hill plate reader. Cytokine production
is expressed in Genzyme U/ml; the limit of detection for the IL-4
and IL-5 ELISA was 
 
.
 
0.2 U/ml and 
 
.
 
70 U/ml, respectively.
 
Results and Discussion
 
Anti–CTLA-4 Treatment Enhances IL-4 and IL-5 Produc-
tion In Vivo.
 
To establish whether T cell effector function
is altered by blockade of CTLA-4 signaling, we followed
IL-4 and IL-5 production in the draining mediastinal and
mesenteric lymph nodes of mice infected with Nb and re-
ceiving weekly injections of anti–CTLA-4 neutralizing
mAb. We found that anti–CTLA-4 mAb treatment induced
a profound 20-fold increase in IL-5 production (Fig. 1 
 
a
 
)
and a massive 40-fold increase in IL-4 production (Fig. 2 
 
a
 
)
from the draining mediastinal lymph node at day 6 after in-
fection compared to mice given control antibody. Signifi-
cantly, the peak mediastinal cytokine production of both
IL-5 and IL-4 during CTLA-4 blockade occurred earlier
Figure 1. Treatment with anti–CTLA-4 greatly enhances IL-5 produc-
tion in lymph nodes draining the sites of infection with Nb. C57BL/6
mice were inoculated i.p. with 1,000 Nb L3 larvae and treated with con-
trol hamster IgG (open squares) or hamster anti–mouse CTLA-4 mAb
(filled squares) at 1 mg/week beginning at day 0. Total lymph node cells
were stimulated in vitro with anti-CD3 and IL-5 levels in the supernatant
measured by ELISA. Values represent the mean concentration of IL-5
produced from 1 3 106 cells from 4 mice and adjusted to IL-5 production
per lymph node based on the total lymph node cell number. Results
shown are representative of three separate experiments. (A) IL-5 produc-
tion from the draining mediastinal lymph node. (B) IL-5 production from
the draining mesenteric lymph node. (C) IL-5 production from the in-
guinal lymph node. This lymph node does not drain any site of Nb infection.
Figure 2. Treatment with anti–CTLA-4 greatly enhances IL-4 produc-
tion in lymph nodes draining the sites of infection with Nb. C57BL/6
mice were inoculated i.p. with 1,000 Nb L3 larvae and treated with con-
trol hamster IgG (open squares) or hamster anti–mouse CTLA-4 mAb
(filled squares) as in Fig. 1. Total lymph node cells were stimulated in vitro
as described in Fig. 1 and IL-4 levels in the supernatant measured by
ELISA. Values represent the mean concentration of IL-4 produced from
1 3 106 cells from four mice and adjusted to IL-4 production per lymph
node based on the total lymph node cell number. Results shown are rep-
resentative of three separate experiments. (A) IL-4 production from the
draining mediastinal lymph node. (B) IL-4 production from the draining
mesenteric lymph node. (C) IL-4 production from the inguinal lymph
node. This lymph node does not drain any site of Nb infection. 
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than that in control mice. Increased cytokine production in
response to CTLA-4 blockade was due to increased lym-
phocyte numbers per mediastinal lymph node as well as in-
creased cytokine production. The mediastinal lymph node
obtained from mice given anti–CTLA-4 mAb had nearly
fourfold more lymphocytes 6 d after infection than control
mice (Fig. 3). Cytokine production in mesenteric lymph
nodes was also significantly increased with anti–CTLA-4
mAb treatment (IL-5; Fig. 1 
 
b
 
, IL-4; Fig. 2 
 
b
 
) but it is inter-
esting that in this lymph node peak cytokine production
occurred at the same time in control and anti–CTLA-4–
treated mice. Increased cytokine production from this lymph
node reflected increased IL-4 and IL-5 production only as
total mesenteric lymph node cell numbers were not signifi-
cantly different between groups (data not shown). The ob-
servation that increased cellularity and cytokine production
only occurred in the lymph nodes draining the site of in-
fection and not the inguinal nodes indicated that the effect
of CTLA-4 blockade was antigen driven (IL-5; Fig. 1 
 
c
 
, IL-4;
Fig. 2 
 
c
 
).
 
Blockade of CTLA-4 Signals Decreases Parasite Egg Produc-
tion.
 
To examine whether the accelerated and increased
response during anti–CTLA-4 mAb treatment could enhance
immunity to the parasite Nb, we examined fecal egg out-
put throughout a primary infection of Nb (Fig. 4 
 
a
 
). CTLA-4
blockade nearly abolished parasite egg production com-
pared to the tens of thousands of eggs produced per day in
control mice. Surprisingly, the numbers of eggs produced
during treatment with anti–CTLA-4 mAb more closely re-
sembled the low numbers observed after a secondary infec-
tion with Nb (Fig. 4 
 
b
 
). Importantly, blockade of CTLA-4
signaling during a primary Nb infection did not adversely
affect development of memory to a subsequent infection
with Nb (Fig. 4 
 
b
 
). This observation differs from prediction
by others that CTLA-4 signaling is required to facilitate the
generation of memory T cells (16). Both groups of mice
show strong memory responses against Nb as evidenced by
the very low level of fecal egg production.
 
Anti–CTLA-4 Treatment Decreases the Peak Intestinal Worm
Burden.
 
The size and characteristics of the adult worm
population found in the small intestine during the peak of
infection is often used as an indicator of the efficacy of the
protective immune response. We found that the number of
adult worms residing in the small intestine at the peak of
infection was reduced to a 24% take in mice treated with
anti–CTLA-4 mAb compared with a 54% take in control
Figure 3. Treatment with anti–CTLA-4 increases total lymphocyte
numbers in mediastinal lymph nodes of Nb-infected mice. C57BL/6 mice
were inoculated i.p. with 1,000 Nb L3 larvae and treated with control
hamster IgG (open squares) or hamster anti–mouse CTLA-4 mAb (filled
squares) as in Fig. 1. Values represent the mean cell number from four
mice 6 SE and results are representative of three separate experiments.
Figure 4. Treatment with anti–CTLA-4 decreases parasite egg output
in a primary Nb infection and does not affect development of memory to
a subsequent infection with Nb. (A) C57BL/6 mice were inoculated i.p.
with 1,000 L3 Nb larvae and left untreated (open squares) or treated with
anti–CTLA-4 neutralizing mAb (filled squares) as described in Fig. 1. Feces
were collected daily from groups of mice (n 5 8) starting day 6 after in-
fection. (B) Mice from A were inoculated i.p. with 1,000 L3 Nb larvae 68 d
after primary Nb infection. During the primary infection mice were un-
treated (open squares) or treated with anti–CTLA-4 mAb (filled squares) as
above. The last injection of mAb was given 21 d after primary infection.
Feces were collected daily from groups of mice (n 5 8) starting day 5 after
challenge. 
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mice (Table 1). Microscopic analysis of the worms resident
in the small intestine revealed that most of the female
worms present in the control mice contained the expected
20–30 eggs, whereas many of the female worms present in
the anti–CTLA-4 treated mice contained few or no visible
eggs. These data suggest that CTLA-4 blockade enhances
the immune response against the migratory larvae resulting
in a reduction in the number of healthy adults that reach
the small intestine, thus reducing both the worm burden
and overall fecundity.
It has been suggested that in vivo blockade of the pro-
posed negative signaling function of CTLA-4 could allow
greater expansion of antigen-specific T cells and possibly
prolong an immune response. Here we report that treat-
 
Table 1.
 
Anti–CTLA-4 mAb Treatment Decreases Worm 
Colonization of the Small Intestine
 
Worms
inoculated
Peak worm
burden
(Day 7)
Development
take
 
%
 
Control mice 750 406 54
Anti–CTLA-4
mAb–treated mice 750 181 24
C57BL/6 mice were infected subcutaneously with 750 Nb L3 larvae
and treated with either anti–CTLA-4 mAb or control hamster IgG (1
mg/week, i.p.). The small intestine was removed 7 d after infection and
adult worm numbers determined per mouse by slicing open the intes-
tine longitudinally, cutting into small sections, and suspending in a
gauze bag submerged in PBS at 37
 
°
 
C to allow worms to migrate out
and settle to the bottom. Microscopic analysis of the small intestine re-
vealed any worms that had remained attached to the intestinal mucosa.
 
ment of mice with anti–CTLA-4 neutralizing mAb during
an acute infection with the extracellular parasite Nb allows
greater expansion and activation of parasite-specific T cells
and this results in greatly enhanced protective immunity
similar to that observed during a memory response. In ad-
dition to the increase in the magnitude of T cell reactivity,
an important aspect of the response induced during CTLA-4
blockade is that the kinetics of the anti-parasite immune re-
sponse is advanced to the point where it is protective. We
postulate that the profoundly enhanced pulmonary response
observed with anti–CTLA-4 treatment leads to immune
damage of the migrating larvae before they reach the intes-
tine, resulting in a lower worm burden and decreased fe-
cundity. This is in concordance with a previous suggestion
that damage to migratory larvae while passing through the
lungs may be an important factor in determining the health
of the adult worm population (17). The greatly enhanced
pulmonary immune response also has the potential to cause
increased tissue damage to the lung. However, we did not
observe any gross increases in pulmonary damage in mice
treated with anti–CTLA-4 mAb. If mice are inoculated
with a higher concentration of infective larvae, many of
them die at the time that the worms pass through the lungs,
presumably due to pulmonary damage. Anti–CTLA-4 mAb
treatment did not lead to an increase in the number of deaths
observed therefore, if there was any increase in tissue dam-
age it did not equal that obtained by a higher infection dose.
Furthermore, although serum IgE levels in the control in-
fected mice increase more than 100-fold, serum IgE levels
in anti–CTLA-4 mAb–treated mice were only very mod-
erately increased (approximately twofold) above that ob-
served in the control animals (data not shown). Blockade of
CTLA-4 function may therefore provide an important
mechanism for enhancing protective immunity against
many infectious agents.
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